A new vaccine has prevented half the cases of shingles in elderly people participating in a trial. When the painful disease did appear, it was generally less severe and cleared up faster than it did in study participants who got an inert shot.
The findings could pave the way for regulatory approval of the experimental vaccine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.